-
Triamcinolone: Practical Research Workflow Guide
2026-09-09
Triamcinolone provides a defined synthetic glucocorticoid agonist for controlled studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses solvent selection, storage, controls, and assay qualification; the compound is for scientific research only and should not be used for diagnostic, clinical, or therapeutic purposes.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-09
Separate mRNA uptake from protein expression with one dual-fluorescence reporter. This practical workflow shows how to use Cy5 tracking and EGFP translation to validate nanoparticles, optimize transfection, and troubleshoot delivery bottlenecks.
-
MRSA Extracellular Vesicles Drive OSCC via IL-8
2026-09-08
A 2026 Journal of Advanced Research study shows that extracellular vesicles from methicillin-resistant Staphylococcus aureus promote oral squamous cell carcinoma growth through an IL-8–CXCR1 signaling relay. By combining MRSA-versus-MSSA comparisons, vesicle uptake and cargo analysis, pathway inhibition, genetic validation, and mouse tumor experiments, the work identifies antibiotic-resistant bacterial vesicles as mechanistically active regulators of tumor progression.
-
Protease Inhibitor Cocktail: Preserve Plant Signals
2026-09-08
Discover how a Protease Inhibitor Cocktail can protect plant signaling proteins while preserving the interpretability of abundance, interaction, and phosphorylation-sensitive assays. This article uses the NSP2–MYB40 symbiosis study to develop a decision framework for plant extract preparation.
-
Hypoxia and Immunometabolism in Tumors
2026-09-07
The 2025 Cancer Letters review presents tumor hypoxia and immune metabolism as a reciprocal system linking oxygen limitation, nutrient competition, metabolic reprogramming, and immune suppression. Its main practical contribution is a framework for designing metabolism-focused tumor studies while identifying why hypoxia- and immunometabolism-targeted therapies may be difficult to translate.
-
TCEP Hydrochloride: Mechanism and Workflow
2026-09-07
Tris(2-carboxyethyl) phosphine hydrochloride, also called TCEP hydrochloride, is a thiol-free, water-soluble reagent for disulfide bond reduction. Its documented uses include protein digestion enhancement, hydrogen-deuterium exchange analysis, dehydroascorbic acid reduction, and selected organic synthesis workflows.
-
EdU Flow Cytometry Assay Kits: Cell Crosstalk
2026-09-05
EdU Flow Cytometry Assay Kits (Cy3) can convert intercellular signaling into a quantitative S-phase readout. This article explains how the K1077 assay can strengthen hypoxia pulmonary hypertension models by separating DNA replication measurement from apoptosis, cell identity, and pathway-specific interpretation.
-
Candida krusei Phases Trigger Distinct Apoptosis
2026-09-04
Miao and colleagues show that the yeast and hypha phases of Candida krusei induce bovine mammary epithelial-cell apoptosis through different dominant pathways. The study links yeast-associated injury to mitochondrial signaling, hypha-associated injury to death ligand/receptor signaling, and both responses to TLR2/ERK and JNK/ERK regulation, providing a framework for phase-specific studies of fungal mastitis.
-
JZL184: MAGL Inhibition in Pain Research
2026-09-04
JZL184 is a selective monoacylglycerol lipase inhibitor for connecting 2-AG metabolism with synaptic, nociceptive, and affective readouts. This workflow-focused guide shows how to prepare the compound, validate CB1-dependent effects, and avoid common lipidomics, electrophysiology, and behavioral assay confounders.
-
Angiotensin II A1042: Practical Research Protocol
2026-09-03
This guide outlines how to prepare and apply Angiotensin II (SKU A1042) in receptor, vascular cell, and vascular remodeling workflows. It distinguishes dossier-supported parameters from laboratory recommendations and identifies where model-specific validation is required; the product is for research use only, not diagnostic or therapeutic use.
-
WP1066: Mapping JAK2/STAT3 Across Cancer and Repair
2026-09-03
WP1066 is a cell-permeable JAK2/STAT3 inhibitor for testing pathway dependence in cancer models, including renal carcinoma and AML. This thought-leadership guide connects its oncology applications with emerging evidence that JAK2-STAT3 signaling also regulates macrophage metabolism and bone regeneration, while defining the limits of cross-domain translation.
-
Lipo3K Transfection Reagent for Resistance Biology
2026-09-02
Explore how Lipo3K Transfection Reagent can support mechanistic studies of paclitaxel resistance, ABC transporter biology, and cholesterol-rich membrane domains. This article presents a causal assay framework rather than another general transfection guide, integrating nucleic acid delivery with rigorous interpretation of cancer-cell phenotypes.
-
LBP, AMPK, and Mitophagy in Skeletal Muscle
2026-09-02
A 2025 study shows that Lycium barbarum polysaccharide alleviates high-fat-diet-associated skeletal muscle atrophy by linking AMPK activation to PINK1/Parkin-mediated mitophagy. Its combined mouse and palmitate-stressed cell models provide mechanistic evidence that improving mitochondrial quality control can also normalize glucose and lipid disturbances in sarcopenic obesity.
-
n-Dodecyl-β-D-maltoside: Assay Design Guide
2026-09-01
Learn how n-Dodecyl-β-D-maltoside (DDM) can be selected and controlled as an experimental variable in membrane-protein purification, folding, and activity assays. Using WecA as a case study, this guide connects detergent chemistry with assay validity rather than treating solubilization as a standalone step.
-
Hepatic sEH–Nrf2 Signaling in Osteoporosis
2026-09-01
A 2025 study identifies a liver–bone axis in which hepatic soluble epoxide hydrolase alters circulating 14,15-EET and 14,15-DHET, suppresses Nrf2–ARE signaling, and promotes osteoclastogenesis. By combining clinical samples, an ovariectomy-induced mouse model, liver-specific knockdown, pharmacological inhibition, and transcriptomics, the work links fatty acid epoxide signaling to redox control of bone remodeling.